Stay updated on Alternative Schedule Study for VLA15 Clinical Trial
Sign up to get notified when there's something new on the Alternative Schedule Study for VLA15 Clinical Trial page.

Latest updates to the Alternative Schedule Study for VLA15 Clinical Trial page
- Check7 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a newer release of the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now shows a new revision version (v3.5.4), replacing the previous v3.5.3. This indicates a minor update to the revision notes without altering substantive content.SummaryDifference0.0%

- Check50 days agoChange DetectedThe site footer revision/version indicator was updated from **v3.5.0** to **v3.5.3**.SummaryDifference0.0%

- Check72 days agoChange DetectedA new publication reference on VLA15 dose optimization (Lancet Infect Dis 2024) was added. The related erratum reference for that publication was removed.SummaryDifference0.0%

- Check86 days agoChange Detected- Updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check100 days agoChange DetectedAdded a Lancet Infect Dis. article citation (with erratum) related to the VLA15 studies and updated the reference version from v3.4.2 to v3.4.3; the older version citation was removed.SummaryDifference0.1%

Stay in the know with updates to Alternative Schedule Study for VLA15 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alternative Schedule Study for VLA15 Clinical Trial page.